-
Research gauges neurodegeneration tied to FXTAS by measuring motor behavior
on October 17, 2019 at 6:28 pm
Researchers used a grip-force test to analyze sensorimotor function in people with the FMR1 premutation, with the aim of determining FXTAS risk and severity.
-
Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease
on October 17, 2019 at 2:12 pm
A team of researchers has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.
-
Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease
on October 17, 2019 at 2:12 pm
A team of researchers has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.
-
Scientists develop test for uncommon brain diseases
on October 16, 2019 at 4:45 pm
Scientists have developed an ultrasensitive new test to detect abnormal forms of the protein tau associated with uncommon types of neurodegenerative diseases called tauopathies. This advance gives them hope of using cerebrospinal fluid, or CSF -- an accessible patient sample -- to diagnose these and perhaps other, more common neurological diseases, such as Alzheimer's disease.
-
Hormone therapy associated with improved cognition
on October 16, 2019 at 11:47 am
Estrogen has a significant role in overall brain health and cognitive function. That's why so many studies focused on the prevention of cognitive decline consider the effect of reduced estrogen levels during the menopause transition. A new study suggests a cognitive benefit from a longer reproductive window complemented with hormone therapy.
